Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
暂无分享,去创建一个
S. Sleijfer | E. D. de Vries | J. Verweij | J. Gietema | W. Loos | N. Fox | F. Eskens | C. Mom | R. Miceli | C. Oldenhuis